Pharmaceuticals

Porcine Epidemic Diarrhea Vaccines Market Forecast 2026: Where the Industry Is Headed

February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the porcine epidemic diarrhea vaccines market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Porcine Epidemic Diarrhea Vaccines Market’s size between 2026 and 2030?

The porcine epidemic diarrhea vaccines market size has experienced strong growth in recent years. It is forecast to rise from $1.8 billion in 2025 to $1.94 billion in 2026, with a compound annual growth rate (CAGR) of 7.6%. This historical expansion can be attributed to factors including recurrent porcine epidemic diarrhea outbreaks, high mortality rates observed in neonatal piglets, economic losses incurred by the swine industry, the limited effectiveness of non-vaccine disease control measures, and an increasing reliance on veterinary-guided disease prevention.

The porcine epidemic diarrhea vaccines market size is anticipated to undergo significant expansion in the foreseeable future. This market is projected to reach $2.5 billion by 2030, demonstrating a compound annual growth rate of 6.7%. The expansion over the forecast period is fueled by the rise of intensive pig farming methods, an increasing global appetite for pork, greater recognition of the advantages of herd immunity, the proliferation of organized hog production farms, and supportive government initiatives concerning animal health. Prominent trends expected during this period include a wider adoption of preventive vaccination in swine health management, a growing inclination towards live vaccines in endemic regions, an intensified focus on early immunization for piglets, the broadening of vaccination programs within commercial hog farms, and a stronger emphasis on biosecurity and protocols for disease control.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp

Which Drivers Are Shaping Strategic Decisions In The Porcine Epidemic Diarrhea Vaccines Market?

Growing pig farming is anticipated to drive the expansion of the porcine epidemic diarrhea vaccine market in the future. This practice encompasses the raising of domestic swine for meat, along with activities like breeding, rearing, managing pigs from birth to market readiness, and the production and sale of pork products. The increase in pig farming stems from escalating worldwide demand for pork, progress in breeding and herd management techniques, enhancements in swine production technologies, and the expansion of commercial pork sectors. Porcine epidemic diarrhea (PED) vaccines are vital in pig farming, assisting in the prevention and control of disease outbreaks, usually given during a sow’s gestation to confer passive immunity to her offspring. An example of this growth is seen in April 2024, when the U.S. Department of Agriculture, a US government body, forecast U.S. pork production to hit 12.7 million metric tons, indicating higher swine output and bolstering the ongoing development of the pig farming industry. Consequently, the expansion of pig farming is stimulating the growth of the porcine epidemic diarrhea vaccine market.

What Segment Categories Are Covered In The Porcine Epidemic Diarrhea Vaccines Market?

The porcine epidemic diarrhea vaccines market covered in this report is segmented –

1) By Product: Live Vaccines, Killed Vaccines

2) By Application: Piglets, Adults Pigs

3) By End-User: Veterinary Hospitals, Hog Production Farms

Subsegments:

1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines

2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines

How Are Emerging Trends Affecting The Progression Of The Porcine Epidemic Diarrhea Vaccines Market?

Leading companies within the Porcine Epidemic Diarrhea (PED) vaccines market are prioritizing the creation of innovative solutions, including next-generation inactivated and recombinant vaccines, to boost immunity and offer wider safeguard against novel PEDV strains. These advanced vaccines utilize either killed viruses or engineered viral proteins to provoke robust, specific immune responses, concurrently enhancing safety and defense against mutating pathogens. For instance, in August 2024, Zoetis Inc., a US-based animal health company, was awarded funding related to Porcine Epidemic Diarrhea Virus (PEDV) vaccine research and also obtained a provisional authorization from the U.S. Department of Agriculture (USDA) for a vaccine designed to combat PEDV in pigs. Such endeavors reinforce Zoetis’s position in crafting advanced swine health solutions by promoting additional investigation, improving vaccine efficacy, and broadening safeguarding against emerging PEDV strains.

Which Key Players Are Driving Competition In The Porcine Epidemic Diarrhea Vaccines Market?

Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, MSD Animal Health, Elanco Animal Health, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Phibro Animal Health Corporation, IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc., Tecnovax, Komipharm International Co. Ltd., Bioveta a.s., HIPRA, CZ Vaccines

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

Which Region Is Projected To Lead The Porcine Epidemic Diarrhea Vaccines Market During The Forecast Period?

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2025. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Porcine Epidemic Diarrhea Vaccines Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16514&type=smp

Browse Through More Reports Similar to the Global Porcine Epidemic Diarrhea Vaccines Market 2026, By The Business Research Company

Porcine Epidemic Diarrhea Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

Porcine Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report

Swine Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795